Bioscience of Microbiota, Food and Health
Online ISSN : 2186-3342
ISSN-L : 2186-3342
Full Paper
Therapeutic potential of Sishen Pill: modulating intestinal mucosal microbiota and barrier function in diarrhea-predominant irritable bowel syndrome with Spleen-Kidney Yang Deficiency
Liwen LI, Qi LONG, Zhoujin TAN, Na DENG
Author information
JOURNAL OPEN ACCESS

2026 Volume 45 Issue 4 Pages 237-253

Details
Abstract

This study aimed to investigate the intestinal microecological mechanisms underlying the effects of Sishen Pill (SSP) on diarrhea-predominant irritable bowel syndrome (IBS-D) with Spleen-Kidney Yang Deficiency Syndrome, thereby providing experimental evidence for clinical management. Murine models of IBS-D characterized by Spleen-Kidney Yang deficiency were established in SPF-grade female Kunming mice by Folium senna-adenine gavage in conjunction with restraint-tail clamping. Experimental groups received SSP decoction or pinaverium bromide suspension. Intestinal morphological changes were assessed via Alcian blue staining. The concentrations of serum D-lactate (D-LA) and diamine oxidase (DAO) were measured through enzyme-linked immunosorbent assay. The intestinal mucosal microbiota was analyzed using 16S rRNA gene sequencing. The model mice exhibited reduced anal temperatures, diarrhea, weight loss, intestinal mucosal barrier injury, and altered mucosal microbiota. SSP treatment alleviated these abnormalities, decreased serum D-LA and DAO levels, and improved the intestinal mucosal structure. Microbiota analysis identified Alkaliphilus as a potential genus associated with SSP intervention, while Streptococcus and Maribacter were correlated with intestinal barrier indicators. These findings suggest that SSP may improve IBS-D with Spleen-Kidney Yang Deficiency by modulating the intestinal mucosal microbiota and restoring mucosal barrier function.

Content from these authors
© 2026 by BMFH Press

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Next article
feedback
Top